A study by Abba et al. showed that more aggressive DCIS (high grade and TN or HER2-positive) displayed signatures characteristic of activated Treg cells (CD4+/CD25+/FOXP3+), consistent with an immunosuppressive phenotype [30]. The gene discussed is FOXP3; the disease is ductal breast carcinoma in situ.